Oakland, CA, United States of America

Stephen F Tuck

USPTO Granted Patents = 19 


 

Average Co-Inventor Count = 2.7

ph-index = 12

Forward Citations = 435(Granted Patents)


Company Filing History:


Years Active: 2006-2015

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: **Stephen F. Tuck: Innovator in Immunomodulatory Compounds**

Introduction

Stephen F. Tuck, based in Oakland, CA, is a prominent inventor in the field of immunology, holding a total of 19 patents. His work focuses on the development of innovative compounds that aim to enhance immunological responses.

Latest Patents

Among his recent inventions, Tuck has developed a patent titled "Chimeric immunomodulatory compounds and methods of using the same-IV." This invention provides immunomodulatory compounds and methods for adjusting the immune response in individuals. Another notable patent is for "Compositions comprising structurally stable conjugate molecules," which emphasizes the creation of stable conjugate molecules at specific temperature ranges, including structures that incorporate allergens like the Ragweed antigen Amb a 1. This work introduces methods for utilizing these compositions to modulate immune responses effectively.

Career Highlights

Stephen F. Tuck has made significant contributions to the field while working at Dynavax Technologies Corporation, a company renowned for its innovations in immunotherapy. His research and inventions demonstrate a commitment to advancing medical science and improving therapeutic interventions.

Collaborations

Throughout his career, Tuck has collaborated with esteemed colleagues such as Karen L. Fearon and Dino Dina, further enhancing the depth and breadth of his research capabilities and facilitating the development of groundbreaking medical solutions.

Conclusion

Stephen F. Tuck is an influential figure in the field of immunology, with a strong portfolio of patents that highlight his innovative spirit. His contributions continue to impact the medical field, promising advancements in the treatment and understanding of immune-related conditions through his work at Dynavax Technologies Corporation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…